Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03401541Phase 1Completed
Phase 1, randomised, double-blind trial of calcifediol in Vitamin D deficiency (VDD) (4 arms), sponsored by Boston University. Primary endpoints: Change in Serum vitamin D status at 2 weeks and Change in 25-Hydroxyvitamin D Status at 2 weeks. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03401541.